Compounds > rolipram
Page last updated: 2024-11-04

rolipram and Adenoma, Prostatic

rolipram has been researched along with Adenoma, Prostatic in 1 studies

Research Excerpts

ExcerptRelevanceReference
"New therapeutic targets in benign prostatic hyperplasia (BPH) mainly concern phosphodiesterase type 5 (PDE-5) inhibitors."1.34[Recent progress in basic research concerning the management of benign prostatic hyperplasia]. ( Cornu, JN; Rouprêt, M, 2007)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cornu, JN1
Rouprêt, M1

Other Studies

1 other study available for rolipram and Adenoma, Prostatic

ArticleYear
[Recent progress in basic research concerning the management of benign prostatic hyperplasia].
    Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie, 2007, Volume: 17, Issue:5 Suppl 1

    Topics: Colforsin; Humans; Male; Muscle Contraction; Muscle, Skeletal; Phenylephrine; Piperazines; Prostatic

2007